For about a decade, scientists have struggled to find an inexpensive, practical alternative to microfluidic probes. Following an experiment by a New York University research team, a new avenue may available to researchers.

Consuming an array of foods sounds reasonable in theory but may ultimately backfire, according to the authors of a scientific advisory statement published online Aug. 9 in Circulation.

Incidental pulmonary nodules detected on chest CT cost a downstream average of $393, researchers reported in a new Academic Radiology study. Collaboration may be the key to reducing that number.

George Hahn of Philadelphia had two echocardiograms conducted at the same hospital a year apart, using the same insurance—the only difference was one cost $3,000 more than the other. Hahn’s plight is similar to many other Americans—and hospitals are acting, reports the Philadelphia Inquirer.

Brain MRIs of children diagnosed with the common genetic syndrome neurofibromatosis type 1 (NFI) displayed an underestimated frequency of brain tumors according to research published in Neurology, Clinical Practice.  

Community Health Systems (CHS) is under investigation over its adoption of electronic health records (EHRs) and adherence to a federal program to fund the technology.

Biopsies of renal masses can safely be performed at the same time as image-guided tumor ablation (IGTA), according to a new study published in the Journal of Vascular and Interventional Radiology.

George Hahn of Philadelphia had two echocardiograms conducted at the same hospital a year apart, using the same insurance—the only difference was one cost $3,000 more than the other. No doubt Hahn’s plight is similar to many other Americans—and hospitals are acting, reports the Philadelphia Inquirer.

Kathryn J. Fowler, MD, and Elizabeth George, MD, have been appointed to the RSNA William R. Eyler Editorial Fellowship and RSNA William O. Olmsted Trainee Editorial Fellowship for 2018, respectively, the Radiological Society of North America (RSNA) announced this week.

Continued use of statins was associated with a 25 percent reduced risk of major adverse cardiovascular events in patients after carotid revascularization, according to a Canadian study with five years of follow-up. But only about two-thirds of patients were taking moderate to high doses of the drugs prior to their procedures.